Connect with us

Technology

Chandigarh University’s Biotechnology & Pharmacy Students Secure 178 Placements with Leading Pharmaceutical and Biotechnology Companies

Published

on

Leading national & global companies like Sun Pharma, GSK, Medtronic India, Serum Institute of India recruit Chandigarh University students

CHANDIGARH, India, July 30, 2026 /PRNewswire/ — The rapid growth of Biotechnology, Pharmaceutical Sciences and allied healthcare fields has triggered a high demand for professionals equipped with specialized knowledge, practical skills and industry exposure. To meet this growing demand, Chandigarh University has integrated experiential learning model into its Biotechnology and Pharmaceutical Sciences programmes with 178 students securing placements and 261 students gaining industry internships in leading pharmaceutical companies, reputed healthcare institutions (hospitals) and life sciences organisations over the past three years.

The University Institute of Biotechnology (UIBT) and University Institute of Pharmaceutical Sciences (UIPS) jointly attracted more than 97 national and multinational companies, healthcare institutions and life sciences organizations including Sun Pharma, GlaxoSmithKline (GSK), Mankind Pharma, Medtronic India, Macleods Pharmaceuticals, Centrient Pharmaceuticals, Serum Institute of India, Bharat Serum and Vaccine Limited, IDS Infotech and Ind-Swift Limited, among others.

Chandigarh University students have also extended their professional footprint beyond India, building careers in the leading international healthcare and pharmaceutical companies in different parts of the world.

Among all premiere companies, IDS Infotech has emerged as the largest recruiter for biotechnology students of CU with eight placement offers while Ind-Swift Limited provided the highest number of job opportunities in the Pharmacy department recruiting 11 students from Chandigarh University.

The University Institute of Biotechnology emerged as the largest contributor to the combined placement performance with 118 students securing placements and 252 students completing internships over the past three years. As many as 65 companies participated in the department’s recruitment process during this period, with 2024-25 emerging as the strongest placement year, when 54 students secured job offers in leading national and international companies.

The students secured job offers from IDS Infotech, Cryoviva Biotech Pvt. Ltd., Bharat Serum and Vaccine Limited, Fitelo India Pvt. Ltd., Mikky Publication Services Pvt. Ltd., Serum Institute of India, Integrated Resources and Macleod Pharmaceutical Ltd among other leading companies. Among these IDS Infotech offered the highest number of job offers which was eight whereas Cryoviva Biotech, Bharat Serum and Vaccine Limited, Fitelo India and Mikky Publication Services offered six job offers each.

At the programme level, MSc Biotechnology recorded the highest number of selections with 59 students securing placements over the three-year period. This was followed by B.Sc. Biotechnology with 27 placements, M.Sc. Industrial Microbiology with 15, M.Sc. Microbiology with 10 and B.Sc. Microbiology with six placements.

The students of Biotechnology and Microbiology secured placements with leading pharmaceutical, biotechnology and healthcare organisations with several graduates receiving attractive salary packages. The highest annual package of ₹8 lakh was secured by students of M.Sc. Biotechnology and M.Sc. Industrial Microbiology in 2023–24 while an M.Sc. Microbiology student secured an annual salary package of ₹7.5 lakh from Wellcove (CGCS Services Inc.) in 2025–26.

The students from University Institute of Pharmaceutical Sciences secured 60 placements and nine industry internships over the past three years.

As many as five students also secured internships with Sun Pharma, one of India’s leading pharmaceutical companies, providing them with valuable industry exposure. The students from the Pharmaceutical Sciences department have secured job placements in top brands such as Ind-Swift Limited, GlaxoSmithKline (GSK), Mankind Pharma, Medtronic India, Macleods Pharmaceuticals, Centrient Pharmaceuticals, ADI Group, Nectar Lifesciences, Psychocare Health and Evalueserve among other leading organisations.

Ind-Swift Limited emerged as the largest recruiter by selecting the highest number of students which was 11. Endo India Par Formulations and Macleods Pharmaceuticals selected five students each while Proelio Technologies and Psychocare Health selected four students each. GlaxoSmithKline (GSK) also recruited three students, while Medtronic India, Mankind Pharma and Centrient Pharmaceuticals provided career opportunities to students from the department.

The department’s placement performance has also been reflected in strong salary packages across programmes. Gehna, a Pharm.D student, secured the highest salary package of ₹9.6 LPA at Karuna Cancer Hospital. Similarly, Ayush Sneh, Atul Chaubey and Armaan, B. Pharmacy students were selected by GlaxoSmithKline (GSK) as Medical Representatives at annual salary packages of ₹7.5 lakh each.

Mandvi Pandey, an M. Pharmacy student, secured a ₹7 lakh annual package as Junior Analyst at Evalueserve. Several students have also secured Quality Assurance and Quality Control roles at Ind-Swift Limited, while others have obtained opportunities in Quality Control and internship-based roles with Macleods Pharmaceuticals and Centrient Pharmaceuticals. Sneha Kumari is working as a Pharmacopoeial Associate at the Indian Pharmacopoeia Commission, Ghaziabad, under the Ministry of Health and Family Welfare, Government of India. Another student of Chandigarh University, Hasan Zubair is serving as Head of the Pharmaceutical Policy Division at the Ministry of Health, Zanzibar, Tanzania. Navpreet Bhullar is working as a Pharmacy Assistant within the healthcare system in Alberta, Canada.

These job placements reflect the diverse career opportunities available to Chandigarh University graduates, with students (graduates) contributing not only to leading private pharmaceutical and healthcare companies but also to national and international public health systems.

The strong placement achievements by students from Chandigarh University are supported by a robust culture of research and innovation. Over the past three years, students have published more than 40 research papers in reputed international journals and publications. Two design patents have been granted, while three patents have been filed. Several students have also qualified CSIR-NET JRF and secured admission to PhD programmes at premier institutions including the Indian Institute of Science (IISc), Bengaluru, IIT Delhi, IIT Roorkee and IIIM Jammu.

The department’s students have also achieved international academic success. Tanish Bhalla was selected for the Erasmus Mundus Joint Master’s Degree in Leading International Vaccinology Education (2024–26). Yashika Hablani secured an opportunity for higher education at the University of Melbourne, Australia, while Vamshi Kadari is working as a Graduate Research Assistant at California State University, Fresno, USA. Ishana Goyal secured admission to the M.Sc. Biotechnology programme at the University of Rome Tor Vergata, Italy.

The entrepreneurial achievements of students have further strengthened Chandigarh University’s reputation as a hub for innovation and entrepreneurship. Vedant Rinwa founded Nutripanda Life Care LLP, while Deepanshi established Nubody&CO. The students have also founded startups including Algazen & Okiss Pvt. Ltd., creating new avenues for innovation and entrepreneurship in the life sciences sector.

About Chandigarh University

Chandigarh University is a NAAC A+ Grade University and QS World Ranked University. This autonomous educational institution is approved by UGC and is located near Chandigarh in the state of Punjab. It is the youngest university in India and the only private university in Punjab to be honoured with A+ Grade by NAAC (National Assessment and Accreditation Council). CU offers more than 109 UG and PG programs in the field of engineering, management, pharmacy, law, architecture, journalism, animation, hotel management, commerce, and others. It has been awarded as The University with Best Placements by WCRC.

Website address: https://www.cuchd.in/

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/chandigarh-universitys-biotechnology–pharmacy-students-secure-178-placements-with-leading-pharmaceutical-and-biotechnology-companies-302839047.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bold Security Extends Endpoint Data Protection to Every AI Interaction

Published

on

By

Bold introduces new layer of endpoint protection, securing data as it moves to copilots, agents, and the tools employees use every day.

NEW YORK, July 30, 2026 /PRNewswire/ — Bold Security today announced a new layer of data protection covering the full range of AI interactions on the endpoint: from prompts and clipboard activity in web-based copilots to file access, MCP payloads, and commands issued by autonomous agents. This announcement extends Bold’s on-device data protection across these AI workflows, giving security teams control at a layer they’ve never been able to fully see.

The endpoint has become the primary place where sensitive data is exposed to AI—and one of the fastest-growing sources of enterprise data risk. According to the Cloud Security Alliance, 65% of enterprises reported an AI-related incident in the past year, and 61% of those incidents involved data exposure. Nearly every one of these interactions touches the endpoint. It’s where data, users, and AI converge—and the one layer network and cloud tools can’t reach. Desktop AI apps can bypass the proxy entirely, while agents communicate and extract data through channels like desktop applications and the command line. DLP was never built to solve that.

“For years, endpoint data exposure was an accepted compromise. Security teams relied on DLP to protect what they could, knowing there were blind spots they couldn’t easily close,” said Nati Hazut, Co-Founder and CEO of Bold. “AI turned those blind spots into one of the biggest challenges enterprises face, because the data organizations care about most now moves through entirely new interactions.”

That gap is what Bold closes. Seeing these interactions is only the start: governance tools can flag that someone used an AI tool, but not what data was involved or whether it was a risk. That takes understanding the data itself, and the context around it: who’s acting, where it’s going, how sensitive it is. The same upload can be routine or a serious risk depending on all of it. That distinction is what Bold makes, on the device, in real time.

Bold now protects every AI interaction on the endpoint:

Web-based AI: prompts, clipboard, and uploads into copilots and chat tools, tied to the account being used.Desktop AI apps: clipboard, uploads, local file access, and the payloads passed through MCP.AI agents and CLI: full sessions, local and remote MCP, and the commands agents run on a user’s behalf.

Bold’s on-device AI monitors and analyzes every one of these interactions locally, in real time, keeping productive AI use flowing and stopping risky activity, without data ever leaving the endpoint.

Bold’s new AI data protection layer is in private preview. Read more about it on our blog and see it in action next week at Black Hat, booth #2970.

About Bold
Bold is real-time data security for the modern endpoint. Bold runs AI directly on the device to classify data by meaning, understand how people and AI interact with it, and prevent sensitive data from leaving in real time. Bold classifies any data, no regex required, and its decisions reflect the account, the destination, and the sensitivity of the data involved. Raw data stays on the endpoint. The result: protection against real risk without slowing people down. Companies like Tekion, eCapital, HiBob, and Cresta trust Bold. Bold can be reached at info@bold.security.

Contact:
Ignacio Ramirez
ignacio@switchpr.com
1-415-517-6708

View original content to download multimedia:https://www.prnewswire.com/news-releases/bold-security-extends-endpoint-data-protection-to-every-ai-interaction-302839086.html

SOURCE Bold Security

Continue Reading

Technology

Balance Point Announces its Investment in ShipSigma

Published

on

By

WESTPORT, Conn., July 30, 2026 /PRNewswire/ — Balance Point Capital Advisors, LLC (“Balance Point”), in conjunction with its affiliated funds, is pleased to announce its investment in ShipSigma (the “Company”). Balance Point provided debt and equity capital to facilitate Inverness Graham Investments’ (“IGI”) recapitalization of the Company.

Founded in 2018, ShipSigma has become a leading parcel and supply-chain optimization partner for small and medium-sized enterprises. Powered by more than 20 billion parcel and less-than-truckload data points, ShipSigma analyzes each customer’s shipping profile to identify and execute opportunities for greater efficiency and savings. The Company combines proprietary cost modeling with carrier expertise to optimize contracts and automate invoice audits.

“Balance Point is thrilled to partner with ShipSigma and IGI on this transaction and support the Company’s next phase of growth” said Adam Sauerteig, Partner at Balance Point. “We believe ShipSigma provides immediately quantifiable and impactful savings for customers in a complex and ever-changing parcel shipping ecosystem, and we look forward to supporting the Company’s expansion.”

“Balance Point continues to be a value-added partner to Inverness Graham,” said IGI Principal Ryan Geary. “ShipSigma represents the fourth executed investment with Balance Point over the past few years; we appreciate their strong support for our investment approach, and we look forward to continuing to find ways to work with Balance Point in the future.”

About Balance Point

Balance Point is an alternative investment manager focused on the lower middle market. With approximately $2.4 billion in assets under management, Balance Point invests debt and equity capital in select lower middle market companies across a variety of investment vehicles. Balance Point takes a long-term, partnership approach to investing and is committed to building lasting relationships with its partners, management teams and intermediaries. Balance Point is a registered investment advisor. Further information is available at www.balancepointcapital.com.

About ShipSigma

ShipSigma is a tech-enabled parcel spend management platform serving middle-market shippers. The Company uses proprietary analytics and carrier contract expertise to offer a white glove service that helps businesses negotiate better contracts with shippers, monitor ongoing contract compliance, and audit invoices. To learn more, visit www.shipsigma.com.

About Inverness Graham

Inverness Graham is a Philadelphia-based, operationally focused private investment firm that partners with innovative, high-growth businesses where technology is transforming traditional industry. With more than $1.8 billion in assets under management, Inverness Graham brings institutional-scale capabilities to the North American lower middle market while maintaining a focused partnership approach with founders and management teams. To learn more, visit www.invernessgraham.com 

Adam H. Sauerteig
Office: 203-652-8555
asauerteig@balancepointcapital.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/balance-point-announces-its-investment-in-shipsigma-302838192.html

SOURCE Balance Point Capital

Continue Reading

Technology

Nuclearn Launches Equipment AI for Real-Time Alarm Diagnosis and Insight at Nuclear Plants

Published

on

By

New AI-powered workflow connects sensor data, work history, and plant documentation, so teams can diagnose equipment issues and manage alarms in minutes, with more confidence.

PHOENIX, July 30, 2026 /PRNewswire/ — Nuclearn, a leading provider of AI solutions purpose-built for the nuclear industry, today announced the launch of Equipment AI, a new product that connects sensor data, work history, operator logs, condition reports, procedures, design documents, and maintenance guidance into a single AI-powered workflow. The product helps nuclear teams diagnose equipment issues and manage alarms in real time and with more confidence.

“Alarm fatigue and the loss of institutional knowledge as our most experienced engineers retire are two of the biggest risks facing this industry,” said Brad Fox, CEO of Nuclearn. “Equipment AI addresses both at once – putting decades of plant experience in front of the engineer at the moment they need it. Leveraging AI to create a meaningful shift in how nuclear utilities approach plant reliability is why we started Nuclearn in the first place, and Equipment AI is a direct result of that mission.”

Nuclear plants monitor thousands of components, and even a routine day can bring a steady stream of low level alarm notifications. Separating a nuisance alarm from a genuine equipment concern is a full-time job, yet the information needed to make that call, including sensor trends and the plant record behind them, typically lives across multiple disconnected systems. Most AI tools analyze either sensor data or maintenance records, but rarely both. Equipment AI reasons across time-series data and unstructured plant information in a single platform, producing a complete picture rather than an isolated chart, alarm, or work order. Beyond sharper diagnostics, it’s also helping the industry preserve decades of engineering knowledge as it prepares for its next generation of workers.

Equipment AI brings together nuclear domain knowledge, utility data integrations, and source-grounded AI workflows, giving teams a purpose-built way to connect equipment data, plant documentation, and operational context in one place. It is built for the systems nuclear teams already use, including plant historian (PI) data, work order systems, and CAP/condition report platforms, and is designed with the security, traceability, and audit-trail requirements the industry expects.

“Most tools challenge teams to find and aggregate sensor trends supporting the paperwork, and the applied first principles engineering behind it. Equipment AI does both at once, giving engineers the full picture of what a piece of equipment has been telling them, not just a fragment of it,” said Lorenzo Slay, Vice President of Product at Nuclearn. “This is especially true in nuclear power, where the context behind an alarm often lives in a work order, a condition report, or a procedure written years ago. Equipment AI brings all of that together in real time, so teams can make a faster, better-informed call.”

Equipment AI is already live at several nuclear plants, where teams are seeing significant improvements in alarm response time and diagnosis speed. It is available for immediate purchase. Visit https://nuclearn.ai/our-product/equipment-ai/ for more information about Equipment AI or to request a demo.

About Nuclearn

Nuclearn is an AI solutions company built by nuclear professionals, for nuclear professionals. Founded in 2021 by industry veterans Brad Fox and Jerrold Vincent, the company develops secure, on-premise, Part 810–compliant AI platforms designed specifically for the nuclear sector.

Utilities face documentation-heavy processes, complex compliance requirements, and rising workforce challenges. Nuclearn’s flagship solutions, including AtomAssist, CAP AI, Engineering AI, and Performance Improvement AI, address these needs by reducing repetitive tasks, improving accuracy, and strengthening regulatory confidence. Each solution is trained on nuclear-specific data, purpose-built to integrate with existing systems such as Maximo and SAP, and equipped with features for traceability, auditability, and safety-conscious decision support.

Headquartered in Phoenix, Arizona, Nuclearn already supports utilities across the U.S., Canada, and the U.K., with deployments live at dozens of reactors. Learn more at www.nuclearn.ai.

Media Contacts

Nuclearn
Brian Critchfield
Vice President of Marketing
brian@nuclearn.ai

Demarco Strategy Group for Nuclearn:
Karen DeMarco
karen@demarcostrategygroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuclearn-launches-equipment-ai-for-real-time-alarm-diagnosis-and-insight-at-nuclear-plants-302838403.html

SOURCE Nuclearn.ai

Continue Reading

Trending